Sol Gel Technologies Net Income
| SLGL Stock | USD 81.01 7.21 9.77% |
As of the 18th of February 2026, Sol Gel has the Risk Adjusted Performance of 0.2117, coefficient of variation of 389.92, and Semi Deviation of 4.35. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sol Gel Technologies, as well as the relationship between them. Please validate Sol Gel Technologies standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Sol Gel is priced more or less accurately, providing market reflects its prevalent price of 81.01 per share. Given that Sol Gel Technologies has jensen alpha of 1.65, we advise you to double-check Sol Gel Technologies's current market performance to make sure the company can sustain itself at a future point.
Sol Gel's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sol Gel's valuation are provided below:Sol Gel Technologies does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sol Gel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Sol Gel Technologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sol Gel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Sol Gel's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sol Gel's market price signifies the transaction level at which participants voluntarily complete trades.
Sol Gel 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sol Gel's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sol Gel.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Sol Gel on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Sol Gel Technologies or generate 0.0% return on investment in Sol Gel over 90 days. Sol Gel is related to or competes with OKYO Pharma, Clene, Coya Therapeutics, Tiziana Life, Pliant Therapeutics, MacroGenics, and Zentalis Pharmaceuticals. Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing ... More
Sol Gel Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sol Gel's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sol Gel Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.54 | |||
| Information Ratio | 0.2487 | |||
| Maximum Drawdown | 28.45 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 13.94 |
Sol Gel Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sol Gel's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sol Gel's standard deviation. In reality, there are many statistical measures that can use Sol Gel historical prices to predict the future Sol Gel's volatility.| Risk Adjusted Performance | 0.2117 | |||
| Jensen Alpha | 1.65 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.2706 | |||
| Treynor Ratio | (0.51) |
Sol Gel February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2117 | |||
| Market Risk Adjusted Performance | (0.50) | |||
| Mean Deviation | 4.23 | |||
| Semi Deviation | 4.35 | |||
| Downside Deviation | 5.54 | |||
| Coefficient Of Variation | 389.92 | |||
| Standard Deviation | 6.03 | |||
| Variance | 36.36 | |||
| Information Ratio | 0.2487 | |||
| Jensen Alpha | 1.65 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.2706 | |||
| Treynor Ratio | (0.51) | |||
| Maximum Drawdown | 28.45 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 13.94 | |||
| Downside Variance | 30.71 | |||
| Semi Variance | 18.94 | |||
| Expected Short fall | (4.99) | |||
| Skewness | 0.526 | |||
| Kurtosis | 1.79 |
Sol Gel Technologies Backtested Returns
Sol Gel is not too volatile given 3 months investment horizon. Sol Gel Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.26, which indicates the firm had a 0.26 % return per unit of risk over the last 3 months. We were able to analyze and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.55% are justified by taking the suggested risk. Use Sol Gel Technologies Risk Adjusted Performance of 0.2117, semi deviation of 4.35, and Coefficient Of Variation of 389.92 to evaluate company specific risk that cannot be diversified away. Sol Gel holds a performance score of 20 on a scale of zero to a hundred. The entity has a beta of -3.01, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Sol Gel are expected to decrease by larger amounts. On the other hand, during market turmoil, Sol Gel is expected to outperform it. Use Sol Gel Technologies expected short fall, and the relationship between the maximum drawdown and rate of daily change , to analyze future returns on Sol Gel Technologies.
Auto-correlation | 0.57 |
Modest predictability
Sol Gel Technologies has modest predictability. Overlapping area represents the amount of predictability between Sol Gel time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sol Gel Technologies price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current Sol Gel price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 48.51 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Sol Gel Technologies reported net income of (10.58 Million). This is 103.1% lower than that of the Pharmaceuticals sector and 115.1% lower than that of the Health Care industry. The net income for all United States stocks is 101.85% higher than that of the company.
Sol Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sol Gel's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sol Gel could also be used in its relative valuation, which is a method of valuing Sol Gel by comparing valuation metrics of similar companies.Sol Gel is currently under evaluation in net income category among its peers.
Sol Fundamentals
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0733 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.65 % | ||||
| Current Valuation | 167.44 M | ||||
| Shares Outstanding | 2.79 M | ||||
| Shares Owned By Insiders | 70.00 % | ||||
| Shares Owned By Institutions | 15.51 % | ||||
| Number Of Shares Shorted | 7.54 K | ||||
| Price To Earning | 11.16 X | ||||
| Price To Book | 7.19 X | ||||
| Price To Sales | 10.84 X | ||||
| Revenue | 11.54 M | ||||
| Gross Profit | 422 K | ||||
| EBITDA | (10.35 M) | ||||
| Net Income | (10.58 M) | ||||
| Cash And Equivalents | 36.61 M | ||||
| Cash Per Share | 1.58 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 15.03 X | ||||
| Book Value Per Share | 11.45 X | ||||
| Cash Flow From Operations | (13.89 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (1.22) X | ||||
| Target Price | 50.0 | ||||
| Number Of Employees | 34 | ||||
| Beta | 1.38 | ||||
| Market Capitalization | 99.1 M | ||||
| Total Asset | 35.85 M | ||||
| Retained Earnings | (230.88 M) | ||||
| Working Capital | 26.01 M | ||||
| Net Asset | 35.85 M |
About Sol Gel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sol Gel Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sol Gel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sol Gel Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sol Gel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Sol Gel Technologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sol Gel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Sol Gel's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sol Gel's market price signifies the transaction level at which participants voluntarily complete trades.